Showing results (1461-1470 of 1,558) with videos related to

Sort By:
Pageof 156
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Genetic Epidemiology|October 27, 2015
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome ArrayTheresa Dankowski, Dorothea Buck, Till F M Andlauer, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
Brain : a Journal of Neurology|January 25, 2015
Genetic variants are major determinants of CSF antibody levels in multiple sclerosisAn Goris, Ine Pauwels, Marte W Gustavsen, et al.
Therapeutic Advances in Neurological Disorders|November 24, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort studyStefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.
Nature Communications|May 24, 2012
Gene-associated markers provide tools for tackling illegal fishing and false eco-certificationEinar E Nielsen, Alessia Cariani, Eoin Mac Aoidh, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
Neuroimage|April 5, 2016
Power estimation for non-standardized multisite studiesAnisha Keshavan, Friedemann Paul, Mona K Beyer, et al.
Blood Advances|May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemiaRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Plos Medicine|October 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortiumSigne Hässler, Delphine Bachelet, Julianne Duhaze, et al.
Pageof 156